1. Home
  2. RGTI vs GPCR Comparison

RGTI vs GPCR Comparison

Compare RGTI & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rigetti Computing Inc.

RGTI

Rigetti Computing Inc.

N/A

Current Price

$15.48

Market Cap

4.7B

Sector

Technology

ML Signal

N/A

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$47.29

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGTI
GPCR
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
3.8B
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
RGTI
GPCR
Price
$15.48
$47.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$30.78
$103.17
AVG Volume (30 Days)
17.8M
540.7K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
35.78
N/A
EPS
N/A
N/A
Revenue
$13,102,000.00
N/A
Revenue This Year
$225.06
N/A
Revenue Next Year
$99.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
59.86
N/A
52 Week Low
$12.53
$18.49
52 Week High
$58.15
$94.90

Technical Indicators

Market Signals
Indicator
RGTI
GPCR
Relative Strength Index (RSI) 44.02 39.65
Support Level $15.30 $46.40
Resistance Level $16.30 $56.63
Average True Range (ATR) 1.01 2.23
MACD -0.19 -0.66
Stochastic Oscillator 0.94 0.99

Price Performance

Historical Comparison
RGTI
GPCR

About RGTI Rigetti Computing Inc.

Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: